Objective
Inflammation plays a key role in the pathogenesis of many relevant diseases with major impact on our health system such as rheumatoid arthritis, inflammatory bowel disease, and glaucomatous diseases, acute and chronic transplant injury. Despite the recent development of new ant-inflammatory drugs, however, the present therapeutic opportunities are not satisfactory because of their limited efficacy and numerous side effects. Recently, a novel mechanism of cytoprotection and immunomodulation by over expression of the stress protein home oxygenise-1 (HO-1) was discovered. The network labs have access to new technologies for the rational design of drugs, modification of the mouse genome, gene transfer, signal transudation and disease models that offer excellent opportunities to study the mechanisms of HO-1 over expression including its downstream processes and to develop novel therapeutic drugs for acute and chronic inflammation.
Fields of science
- medical and health sciencesclinical medicinerheumatology
- medical and health sciencesmedical biotechnologygenetic engineeringgene therapy
- medical and health sciencesclinical medicinegastroenterologyinflammatory bowel disease
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- natural sciencesbiological sciencesgeneticsgenomes
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
10117 Berlin
Germany
See on map
Participants (7)
16672 Glyfada (Attiki)
See on map
44035 Nantes
See on map
1000 Lisboa
See on map
69007 Lyon
See on map
6500 GL Nijmegen
See on map
91058 Erlangen
See on map
WC1E 7HX London
See on map